Real-world use of botulinum toxin-A for post-stroke spasticity in the Netherlands: a retrospective claims study.

ABSTRACT:

Objective

The aim of this observational study was to describe the real-world use of botulinum toxin-A in patients with a stroke in the Netherlands.

Methods

This study used longitudinal insurance claims data between 2012 and 2016 with 30% nationwide coverage and included patients with both stroke-related and botulinum toxin-A claims. All analyses were descriptive and displayed as summary statistics.

Results

60,222 patients with a stroke were identified, of whom 18,141 (30.1%) were treated in a rehabilitation centre or hospital and 1.7% (1,036 patients) were treated with botulinum toxin-A. A total of 2,855 botulinum toxin-A claims from 890 patients were included in the analysis (1.5% of all patients in the database). Mean age was 63.4 (SD ± 14.0) years at index injectio

SUBMITTER: Van Wijk M 

PROVIDER: S-EPMC12814239 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature